Welcome and Introduction

Helene Langevin, MD
Richard Hodes, MD
Catherine Meyers, MD
Wendy Weber, ND, PhD, MPH

Keynote: Pragmatic Trials Involving Group Randomization or Delivery of Interventions to Groups: GRTs, IRGTs, and SW-GRTs

David Murray, PhD

Panel 1: Measurement and Data: Outcomes, Exposures, and Subgroups Based on EHR Data

Moderator: Rui Wang, PhD

Panel:

• • Pragmatic Trial of Video Education in Nursing Homes (PROVEN) (Vince Mor, PhD; Roee Gutman, PhD)

• • STrategies to Reduce Injuries and Develop confidence in Elders (STRIDE) (Nancy Latham, PhD, PT; Dave Ganz, MD, MPH; Peter Peduzzi, PhD)

• • Active Bathing to Eliminate (ABATE) Infection (Susan Huang, MD, MPH, Ken Kleinman, ScD)

Panel 2: To Cluster or Not to Cluster?

Moderator: Keith Goldfeld, DrPH

Panel:

• • Improving Chronic Disease Management with Pieces (ICD-Pieces™) (Miguel Vazquez, MD; Chul Ahn, PhD)
    
  • Collaborative Care for Chronic Pain in Primary Care (PPACT) (Lynn DeBar, PhD, MPH; William Vollmer, PhD)
  • Suicide Prevention Outreach Trial (SPOT) (Greg Simon, MD, MPH; Susan Shortreed, PhD)

Panel 3: Choosing a Parallel Group or Stepped-Wedge Design

Moderator: Fan Li, PhD

Panel:

• • Lumbar Imaging with Reporting of Epidemiology (LIRE) (Jerry Jarvik, MD, MPH; Patrick Heagerty, PhD)
    
  • Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder (EMBED) (Ted Melnick, MD, MHS; Jim Dziura, MPH, PhD)
  • A Policy-Relevant U.S. Trauma Care System Pragmatic Trial for PTSD and Comorbidity (Trauma Survivors Outcomes and Support [TSOS]) (Doug Zatzick, MD; Patrick Heagerty, PhD)

Panel 4: Unique Complications

Moderator: Andrea Cook, PhD

Panel:

• • Pragmatic Trial of Higher vs. Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis (HiLo) (Myles Wolf, MD; Hrishikesh Chakraborty, DrPH)
  • Strategies and Opportunities to Stop Colorectal Cancer in Priority Populations (STOP CRC) (Bev Green, MD, MPH; William Vollmer, PhD)
  • Time to Reduce Mortality in End-Stage Renal Disease (TiME) (Laura Dember, MD; J. Richard Landis, PhD; Jesse Hsu, PhD)

Summary and Concluding Remarks